ArticleInfectious diseases and therapy2024

Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.

Russell M Nichols et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.